Multiple sclerosis trials in Taiwan

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  Where

  Taipei

  Age

  10 years to 17 years

  People

  194 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06408259 · EU 2022-501332-42-00
• Phase 1/2Taking people
  Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis

  Where

  Taichung

  Age

  20 years to 65 years

  People

  41

  Run by

  Ever Supreme Bio Technology Co., Ltd.

  See details and how to joinNCT05532943